BERLIN, GERMANY (UroToday.com) - Mitchell C. Benson, MD, Professor and Chair of Urology at Columbia University Medical Center reported on his institutional experience with intravesical docetaxel as a salvage therapy for patients with high grade disease who had failed at least one course on intravesical BCG.
Your session will expire in 8 hours requiring you to log in each day to view content.